Nektar Therapeutics (NKTR)

37.68 +2.32 (+6.56%) USD  |  NASDAQ  |  Jan 16, 16:00
37.70 +0.02 (+0.05%) After-Hours: 20:00
More

Nektar Therapeutics Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade
Eli Lilly & Co. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade